Copernicus Therapeutics Incorporated

Copernicus Therapeutics, Inc. is a privately-held company developing products for human gene therapy and vaccination. Copernicus was established in 1997 based on technologies discovered at Case Western Reserve University that provide the foundation for the use of DNA as drugs.Copernicus is not involved in gene discovery or the linkage of genetic defects to disease. Copernicus' business focuses on using its technologies to make and sell gene therapy products to treat, cure or prevent human diseases - products that work.

Contact Details: 11000 Cedar Avenue, Suite 120 Cleveland OH 44106-3052 United States of America Tel: 216-231-0227 Fax: 216-231-9477 Email: WWW: www.cgsys.com/

Loading...

Recent Publications by Copernicus Therapeutics Incorporated:
Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles. Nanoparticles consisting of single molecules of DNA condensed with...	16th September, 2006	Copernicus Therapeutics Inc., Cleveland, OH, USA.	Gene Ther. 2006 Jul;13(13):1048-51. Epub 2006 Mar 9. DOI Direct Link

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 305 times since April 2007, the link to the organisation's website has been followed 89 times

Recent Search Terms used to find this page: Copernicus Therapeutics | Copernicus Therapeutics | .

Search for more companies in Cleveland

Search for more companies in OH

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Copernicus Therapeutics Incorporated